Main container

Studio di oncologia personalizzata per la valutazione di terapie bersaglio nel trattamento di sarcomi muscolo scheletrici

Title
Studio di oncologia personalizzata per la valutazione di terapie bersaglio nel trattamento di sarcomi muscolo scheletrici
Code
PENELOPE
Type
Sperimentale
Start Year
2023
Status
Terminato

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in

Clinical Trial
A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors
Read more
Clinical Trial
Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors
Read more
Content updated
10/11/2023 12:06